NCT00722033

Brief Summary

Very low birth weight infants has increased dramatically their survival. Survival without neurologic disturbance varies a lot between centers.There is evidence that fluctuations in cerebral blood flow influences the appearance of intraventricular hemorrhage and itself implies a detrimental neurologic developing.The electroencephalography is the result of electric base membrane activity on rest, and it's influenced by the blood flow either. The Amplitude-integrated electroencephalography is a novel tool, that is capable to be continuously used at the patient bed and is easily to be read by the trained clinician.The hypothesis is that common procedures as Surfactant instilation, Indomethacin and Aminophyline infusion as the appearance of apneas alters the aEEG register. It is a prospective study that tries to recruit 10 \< 30 weeks of gestational age with aprofen consent to monitorize the aEEG since birth to the seventh day of live.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Aug 2008

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 25, 2008

Completed
7 days until next milestone

Study Start

First participant enrolled

August 1, 2008

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2009

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

August 18, 2008

Status Verified

July 1, 2008

Enrollment Period

1 year

First QC Date

July 23, 2008

Last Update Submit

August 13, 2008

Conditions

Keywords

pretermaEEGapneassurfactantindomethacinaminophyline

Outcome Measures

Primary Outcomes (1)

  • aEEG voltage amplitude changes after procedures

    right after procedure

Secondary Outcomes (1)

  • aEEG amplitude voltage changes between 3 administration protocols of Indomethacin

    right after procedure

Study Arms (1)

A

OTHER

\< 30 weeks of gestation

Drug: 3 protocols of Indomethacin administration

Interventions

Indomethacin will consecutive be infused in 30, 60 and 120 minutes in each patient who requires it.

Also known as: indomethacin
A

Eligibility Criteria

AgeUp to 30 Minutes
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • \< 30 weeks of gestational age
  • Consent inform approved

You may not qualify if:

  • Known mayor malformation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Puc, Nicu

Santiago, Santiago Metropolitan, 833-0024, Chile

Location

Related Publications (2)

  • Burdjalov VF, Baumgart S, Spitzer AR. Cerebral function monitoring: a new scoring system for the evaluation of brain maturation in neonates. Pediatrics. 2003 Oct;112(4):855-61. doi: 10.1542/peds.112.4.855.

    PMID: 14523177BACKGROUND
  • Hellstrom-Westas L, Rosen I. Continuous brain-function monitoring: state of the art in clinical practice. Semin Fetal Neonatal Med. 2006 Dec;11(6):503-11. doi: 10.1016/j.siny.2006.07.011. Epub 2006 Oct 24.

    PMID: 17067863BACKGROUND

MeSH Terms

Conditions

Premature BirthApnea

Interventions

Indomethacin

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

IndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 23, 2008

First Posted

July 25, 2008

Study Start

August 1, 2008

Primary Completion

August 1, 2009

Study Completion

December 1, 2009

Last Updated

August 18, 2008

Record last verified: 2008-07

Locations